PCNSL

3 drugs in development·2 companies·0 clinical trials

Drug Pipeline by Phase

Phase 3(2)

Drug	Company
epcoritamab	GH Research PLC (GHRS)
PD -1/PD-L1 monoclonal antibody	ENANTA PHARMACEUTICALS INC (ENTA)

Phase 2(1)

Drug	Company
Orelabrutinib	ENANTA PHARMACEUTICALS INC (ENTA)

Full trial data, competitive analysis, and AI-powered pipeline tracking.